Novobismol Tablets p / o 120 mg, No. 112
Package quantity, pcs:
56
112
Category
Ulcer and gastritis
,
Antacids
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
112
Novobismol tab.
p / o captivity.
120mg No. 112
Name ENG
NOVOBISMOL
Clinical and pharmacological group
A drug that has a protective effect on the mucous membrane of the stomach and duodenum.
Antiulcer drug
ATX code
Bismuth subcitrate
Dosage
120mg
Structure
Active ingredients: bismuth tripotassium dicitrate 304.6 mg, which corresponds to the content of bismuth oxide 120 mg
Excipients: corn starch - 70.6 mg, povidone K 30 - 17.7 mg, potassium polyacrylate - 23.6 mg, macrogol 6000 - 6.0 mg, magnesium stearate - 2.0 mg
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 4 years
INN / Active ingredient
Bismuth tripotassium dicitrate
Specifications
Category
Ulcer and gastritis
,
Antacids
Scope of the drug
Gastrointestinal tract
Release form
Tablet
Manufacturer country
Russia
Package quantity, pcs
112
Scope of application
Gastroenterology
Minimum age from
4 years old
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Pharmproject
The amount of the dosage form in the primary package
8 pcs.
Primary packaging type
Blister
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antiseptic intestinal and astringent
Anatomical and therapeutic characteristics
A02BX05 Bismuth tripotassium dicitrate
Dosage form
Film-coated tablets
Packaging
Box
The target audience
Adult
Expiration date in days
1461
Package weight, g
80
Mode of application
:
Adults and children over 4 years of age - inside 2-4 times a day 30 minutes before meals.
The dose of Novobismol depends on the patient's age.
The course of treatment is 4-8 weeks.
For the next 8 weeks, do not take bismuth-containing drugs.
For the eradication of Helicobacter pylori, it is advisable to use bismuth tripotassium dicitrate in combination with antibacterial drugs that have anti-Helicobacter activity.
Dosage (volume) of the substance in the preparation
:
1 tab.
bismuth tripotassium dicitrate 304.6 mg, calculated as bismuth oxide (Bi2O3) 120 mg